rs2645339
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000843.4(GRM6):c.1227C>T(p.Tyr409Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.54 in 1,613,020 control chromosomes in the GnomAD database, including 237,047 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.50 ( 19491 hom., cov: 33)
Exomes 𝑓: 0.54 ( 217556 hom. )
Consequence
GRM6
NM_000843.4 synonymous
NM_000843.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.947
Publications
22 publications found
Genes affected
GRM6 (HGNC:4598): (glutamate metabotropic receptor 6) L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Mutations in this gene result in congenital stationary night blindness type 1B. [provided by RefSeq, May 2018]
ZNF454 (HGNC:21200): (zinc finger protein 454) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 5-178989062-G-A is Benign according to our data. Variant chr5-178989062-G-A is described in ClinVar as Benign. ClinVar VariationId is 99626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.947 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.547 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GRM6 | ENST00000517717.3 | c.1227C>T | p.Tyr409Tyr | synonymous_variant | Exon 7 of 11 | 5 | NM_000843.4 | ENSP00000430767.1 |
Frequencies
GnomAD3 genomes AF: 0.500 AC: 75981AN: 151878Hom.: 19464 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
75981
AN:
151878
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.528 AC: 131968AN: 249712 AF XY: 0.523 show subpopulations
GnomAD2 exomes
AF:
AC:
131968
AN:
249712
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.544 AC: 794400AN: 1461024Hom.: 217556 Cov.: 49 AF XY: 0.539 AC XY: 391933AN XY: 726812 show subpopulations
GnomAD4 exome
AF:
AC:
794400
AN:
1461024
Hom.:
Cov.:
49
AF XY:
AC XY:
391933
AN XY:
726812
show subpopulations
African (AFR)
AF:
AC:
13129
AN:
33460
American (AMR)
AF:
AC:
25375
AN:
44662
Ashkenazi Jewish (ASJ)
AF:
AC:
12385
AN:
26128
East Asian (EAS)
AF:
AC:
21856
AN:
39672
South Asian (SAS)
AF:
AC:
38959
AN:
86214
European-Finnish (FIN)
AF:
AC:
29986
AN:
53362
Middle Eastern (MID)
AF:
AC:
2440
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
618246
AN:
1111402
Other (OTH)
AF:
AC:
32024
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
22782
45564
68347
91129
113911
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
17398
34796
52194
69592
86990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.500 AC: 76047AN: 151996Hom.: 19491 Cov.: 33 AF XY: 0.502 AC XY: 37288AN XY: 74310 show subpopulations
GnomAD4 genome
AF:
AC:
76047
AN:
151996
Hom.:
Cov.:
33
AF XY:
AC XY:
37288
AN XY:
74310
show subpopulations
African (AFR)
AF:
AC:
16541
AN:
41444
American (AMR)
AF:
AC:
8076
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
1651
AN:
3464
East Asian (EAS)
AF:
AC:
2887
AN:
5120
South Asian (SAS)
AF:
AC:
2272
AN:
4826
European-Finnish (FIN)
AF:
AC:
5931
AN:
10584
Middle Eastern (MID)
AF:
AC:
133
AN:
294
European-Non Finnish (NFE)
AF:
AC:
37266
AN:
67956
Other (OTH)
AF:
AC:
1008
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1936
3873
5809
7746
9682
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1915
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3Other:1
-
Department of Ophthalmology and Visual Sciences Kyoto University
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Retina International
Significance:not provided
Review Status:no classification provided
Collection Method:literature only
- -
not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Nov 10, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Congenital stationary night blindness 1B Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.